Cargando…

Up-regulated and interrelated expressions of GINS subunits predict poor prognosis in hepatocellular carcinoma

The GINS complex is one of the core components of the eukaryotic replicative helicase CMG (Cdc45–MCM helicase–GINS) complex that serves as the replicative helicase unwinding duplex DNA ahead of moving replication fork during chromosome duplication. Many studies have highlighted the important functio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lian, Yi-Fan, Li, Shan-Shan, Huang, Yan-Lin, Wei, Huan, Chen, Dong-Mei, Wang, Jia-Liang, Huang, Yue-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435550/ https://www.ncbi.nlm.nih.gov/pubmed/30413605 http://dx.doi.org/10.1042/BSR20181178

Ejemplares similares

Expression and prognosis analysis of GINS subunits in human breast cancer
por: Li, Hongtao, et al.
Publicado: (2021)

Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients
por: Liu, Binfeng, et al.
Publicado: (2021)

Overexpression of GINS4 Is Associated With Tumor Progression and Poor Survival in Hepatocellular Carcinoma
por: Zhang, Ziying, et al.
Publicado: (2021)

Overexpressing PLOD family genes predict poor prognosis in gastric cancer
por: Li, Shan-Shan, et al.
Publicado: (2020)

Expression Profile of GINS Complex Predicts the Prognosis of Pancreatic Cancer Patients
por: Bu, Fanqin, et al.
Publicado: (2020)

Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma
por: Cheng, Ya, et al.
Publicado: (2016)

Increased mediator complex subunit 15 expression is associated with poor prognosis in hepatocellular carcinoma
por: Wang, Kunyuan, et al.
Publicado: (2018)

Comprehensive analysis of GINS subunits prognostic value and ceRNA network in sarcoma
por: Zhou, Chuqiao, et al.
Publicado: (2022)

Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma
por: Wang, Ying, et al.
Publicado: (2015)

Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma
por: Li, Zuyin, et al.
Publicado: (2022)

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2014)

Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma
por: Zuo, Shan-Ru, et al.
Publicado: (2018)

High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Lee, Boin, et al.
Publicado: (2014)

Peculiar Gin Accident
por: Oliver, J. P.
Publicado: (1905)

Roles of DSCC1 and GINS1 in gastric cancer
por: Hou, Shiyang, et al.
Publicado: (2023)

Embryonic Morphogen Nodal Is Associated with Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Chen, Jing, et al.
Publicado: (2014)

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

Down-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinoma
por: Sun, Wu-Yi, et al.
Publicado: (2016)

High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma
por: Li, Songwei, et al.
Publicado: (2021)

Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis
por: Yeh, Hsi-Wen, et al.
Publicado: (2017)

Combined analysis of expression, prognosis and immune infiltration of GINS family genes in human sarcoma
por: Zhang, Kexin, et al.
Publicado: (2022)

A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma
por: Lai, Tianqi, et al.
Publicado: (2023)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Xu, Wenxiong, et al.
Publicado: (2022)

Holland Gin as a Medicine
Publicado: (1852)

Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2019)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

The archaeo-eukaryotic GINS proteins and the archaeal primase catalytic subunit PriS share a common domain
por: Swiatek, Agnieszka, et al.
Publicado: (2010)

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
por: Chen, Jiewei, et al.
Publicado: (2018)

Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma
por: Wang, Ya-Bin, et al.
Publicado: (2019)

Up-regulation of LncRNA SNHG20 Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Dongyan, et al.
Publicado: (2016)

GTSE1 promotes SNAIL1 degradation by facilitating its nuclear export in hepatocellular carcin oma cells
por: Li, Shan-Shan, et al.
Publicado: (2021)

MicroRNA miR-502-5p inhibits ovarian cancer genesis by downregulation of GINS complex subunit 2
por: Zhan, Lili, et al.
Publicado: (2021)

Molecular architecture of the human GINS complex
por: Boskovic, Jasminka, et al.
Publicado: (2007)

DNA replication: archaeal oriGINS
por: Bell, Stephen D
Publicado: (2011)

RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma
por: Wang, Wei, et al.
Publicado: (2017)

Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker
por: Meng, Wei, et al.
Publicado: (2022)

GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis
por: Wu, Xiaojuan, et al.
Publicado: (2017)

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
por: Zhu, Zebin, et al.
Publicado: (2018)

Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
por: Sun, Yifan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j2e198eaiug5ujb8t2gu0jdnvt